Citius Oncology, Inc. (CTOR) vs ImmuCell Corporation (ICCC)

A side-by-side comparison of Citius Oncology, Inc. and ImmuCell Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Citius Oncology, Inc. logo
CTOR
Citius Oncology, Inc.
$84M
$0.90HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT
ImmuCell Corporation logo
ICCC
ImmuCell Corporation
$90M
$10.00HealthcareDelayed quote: Oct 6, 2026, 12:24 PM EDT

Total return — CTOR vs ICCC

growth of $100 · dividends reinvested · last 2y
CTOR -92.4% (-72.4%/yr)ICCC +134.9% (+53.3%/yr)ICCC compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020252026$8$235
CTOR ICCC

CTOR vs ICCC: by the numbers

  • •ICCC is the larger company ($90M vs $84M market cap).
  • •ICCC is profitable (2.57% net margin) while CTOR runs a net loss (-648.32%).

Metrics side by side

Valuation

MetricCTORICCC
P/E ratioN/A118.20
Forward P/E9.00N/A
P/S ratio11.782.95
P/B ratio2.072.88
EV / EBITDAN/A15.05
FCF yieldN/A4.66%

Profitability

MetricCTORICCC
Gross margin0.00%40.32%
Operating margin0.00%12.60%
Net margin-648.32%2.57%
ROE-114.06%2.51%
ROIC-88.72%8.16%

Growth (annualized)

MetricCTORICCC
Revenue CAGR (5Y)N/A13.74%
Total return CAGR (5Y)N/A0.65%

Frequently asked

Is CTOR or ICCC more profitable?
ICCC runs the higher net margin — CTOR at -648.32% versus ICCC at 2.57%.

Go deeper

Full CTOR analysisFull ICCC analysisInteractive comparison tool

Dig into the metrics

ImmuCell P/E ratioCitius Oncology ROEImmuCell ROECitius Oncology operating marginImmuCell operating marginCitius Oncology revenue growthImmuCell revenue growthCitius Oncology free cash flowImmuCell free cash flow

Citius Oncology & ImmuCell appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.